Follow
David R. Liu
David R. Liu
Verified email at fas.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1
M Tahiliani, KP Koh, Y Shen, WA Pastor, H Bandukwala, Y Brudno, ...
Science 324 (5929), 930-935, 2009
65722009
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
AC Komor, YB Kim, MS Packer, JA Zuris, DR Liu
Nature 533 (7603), 420-424, 2016
52332016
Programmable base editing of A• T to G• C in genomic DNA without DNA cleavage
NM Gaudelli, AC Komor, HA Rees, MS Packer, AH Badran, DI Bryson, ...
Nature 551 (7681), 464-471, 2017
38862017
Search-and-replace genome editing without double-strand breaks or donor DNA
AV Anzalone, PB Randolph, JR Davis, AA Sousa, LW Koblan, JM Levy, ...
Nature 576 (7785), 149-157, 2019
38802019
Scaling of theory‐of‐mind tasks
HM Wellman, D Liu
Child development 75 (2), 523-541, 2004
29502004
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
26982018
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
DW Huang, BT Sherman, Q Tan, J Kir, D Liu, D Bryant, Y Guo, ...
Nucleic acids research 35 (suppl_2), W169-W175, 2007
22802007
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
V Pattanayak, S Lin, JP Guilinger, E Ma, JA Doudna, DR Liu
Nature biotechnology 31 (9), 839-843, 2013
19172013
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
AV Anzalone, LW Koblan, DR Liu
Nature biotechnology 38 (7), 824-844, 2020
18002020
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
JH Hu, SM Miller, MH Geurts, W Tang, L Chen, N Sun, CM Zeina, X Gao, ...
Nature 556 (7699), 57-63, 2018
16372018
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a …
ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ...
The lancet oncology 15 (7), 700-712, 2014
16122014
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
JA Zuris, DB Thompson, Y Shu, JP Guilinger, JL Bessen, JH Hu, ...
Nature biotechnology 33 (1), 73-80, 2015
15912015
Base editing: precision chemistry on the genome and transcriptome of living cells
HA Rees, DR Liu
Nature reviews genetics 19 (12), 770-788, 2018
15632018
CRISPR-based technologies for the manipulation of eukaryotic genomes
AC Komor, AH Badran, DR Liu
Cell 168 (1), 20-36, 2017
12802017
Sequence-controlled polymers
JF Lutz, M Ouchi, DR Liu, M Sawamoto
Science 341 (6146), 1238149, 2013
12792013
Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification
JP Guilinger, DB Thompson, DR Liu
Nature biotechnology 32 (6), 577-582, 2014
11992014
CRISPResso2 provides accurate and rapid genome editing sequence analysis
K Clement, H Rees, MC Canver, JM Gehrke, R Farouni, JY Hsu, MA Cole, ...
Nature biotechnology 37 (3), 224-226, 2019
11442019
A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ...
Cell 175 (4), 984-997. e24, 2018
11182018
Methods for the directed evolution of proteins
MS Packer, DR Liu
Nature Reviews Genetics 16 (7), 379-394, 2015
11002015
A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog
JK Ichida, J Blanchard, K Lam, EY Son, JE Chung, D Egli, KM Loh, ...
Cell stem cell 5 (5), 491-503, 2009
9732009
The system can't perform the operation now. Try again later.
Articles 1–20